Actualités Cesca Therapeutics Inc - KOOL | Actions NASDAQ

Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic Focus

Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic Focus ThermoGenesis to Focus on Developing Automated Cell Processing...

Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference

Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference PR Newswire RANCHO CORDOVA, Calif., Oct. 24...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Serv...

Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Services ImmuneCyte to...

Cesca Therapeutics To Present At The 2019 Bio Investor Forum

Cesca Therapeutics To Present At The 2019 Bio Investor Forum PR Newswire RANCHO CORDOVA, Calif., Oct. 14, 2019 RANCHO CORDOVA, Calif., Oct. 14...

Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution Fee

Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution Fee PR Newswire RANCHO CORDOVA, Calif., Oct. 2, 2019 RANCHO CORDOVA...

ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing Devices

ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing Devices PR Newswire RANCHO CORDOVA, Calif., Sept. 25, 2019 RANCHO...

Amended Current Report Filing (8-k/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendm...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Securities Registration: Employee Benefit Plan (s-8)

As filed with the Securities and Exchange Commission on September 12, 2019 ...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products

Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products PR Newswire RANCHO...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cesca Therapeutics Inc (KOOL)

Votre Hub pour des idées et discussions en direct en temps réel

KOOL Actualités

Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic Focus

Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference

Current Report Filing (8-k)

Current Report Filing (8-k)

Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Serv...

Cesca Therapeutics To Present At The 2019 Bio Investor Forum

Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution Fee

ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing Devices

Amended Current Report Filing (8-k/a)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Securities Registration: Employee Benefit Plan (s-8)

Current Report Filing (8-k)

Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cesca Therapeutics Inc (KOOL) Actualités

Cesca Therapeutics Inc (KOOL)

Votre Hub pour des idées et discussions en direct en temps réel

KOOL Actualités

Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic Focus

Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference

Current Report Filing (8-k)

Current Report Filing (8-k)

Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Serv...

Cesca Therapeutics To Present At The 2019 Bio Investor Forum

Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution Fee

ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing Devices

Amended Current Report Filing (8-k/a)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Securities Registration: Employee Benefit Plan (s-8)

Current Report Filing (8-k)

Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application